Welcome to Lavipharm

Lavipharm is a dynamic, international healthcare company driven by creativity and innovation, always striving to provide access to improved healthcare solutions.

Research & Innovation



Patnering with Lavipharm


Pharmacy Network



Focusing on cure of human diseases and treatment of simple health problems we launch in the Greek pharmacy market a wide range of prescribed medicines (Rx), OTCs and Dermocosmetics.

We aim at offering reliable therapeutic options to physicians and pharmacists. Our product portfolio include innovative, safe and effective therapeutic solutions that meet consumer’ needs for health and wellbeing.

Our main product categories are: Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment (OTC) and Dermocosmetic care.

Investor Relations

Find in this section all the necessary information for the listed Lavipharm SA, the Historical Share Prices, the Share Capital History, the Shareholders and the main shareholders of Lavipharm SA

Pharma PLUS Network

From the mid 70’s, we are innovative in the area of the Greek pharmacy not only by offering advanced products, but also with pioneering services. In 2003, we established a new company, Pharma PLUS with a goal to offer exclusive services in the Greek pharmacies leading them to developed business units as well as model shops of health and beauty.


CASTALIA products have been marketed since 1992. They have been developed by the Lavipharmresearch centres in Greece and abroad, following international quality standards and based on clinical trials.